Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-16

Clinical Trial Update: An Evaluation of Insomnia Treatment to Reduce Cardiovascular Risk in Patients With Posttraumatic Stress Disorder [NA]

View source ↗

Summary

Clinical trial evaluating insomnia treatment to reduce cardiovascular risk in patients with posttraumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Insomnia, Posttraumatic Stress Disorder | NA | Status: COMPLETED